Filed: 2/14/2025ACC: 0001104659-25-013870
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 28 equity positions with a total reported market value of $466.23M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
28
Positions
$466.23M
Total AUM (reported)
67.01M
Total Shares
Allocation by class
COM$453.13M97.2%
SHS$7.96M1.7%
ADR$5.00M1.1%
WARRANTS$148.6K0.0%
Portfolio Concentration
Top 3$305.79M65.6%
4–10$84.29M18.1%
11–25$75.32M16.2%
Rest$831.3K0.2%
Top 3 weight
65.6%
Top 10 weight
83.7%
Voting Authority Distribution
Total shares with voting rights: 67.01M
Sole
Full voting authority
67.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole28
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings28
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$182.74M
39.20%
Sole
6.37M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$69.04M
14.81%
Sole
25.95M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares3.29M
TypeSH
Market value$54.01M
11.58%
Sole
3.29M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares770K
TypeSH
Market value$19.79M
4.24%
Sole
770K
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares94.77K
TypeSH
Market value$12.66M
2.72%
Sole
94.77K
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares808.79K
TypeSH
Market value$12.04M
2.58%
Sole
808.79K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares76.77K
TypeSH
Market value$12.03M
2.58%
Sole
76.77K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares226K
TypeSH
Market value$9.89M
2.12%
Sole
226K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares171.60K
TypeSH
Market value$9.29M
1.99%
Sole
171.60K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares167.96K
TypeSH
Market value$8.59M
1.84%
Sole
167.96K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.88M
TypeSH
Market value$7.96M
1.71%
Sole
4.88M
Shared
0.00
None
0.00
MERUS NV
SOLEShares189.10K
TypeSH
Market value$7.95M
1.71%
Sole
189.10K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares11.91M
TypeSH
Market value$7.62M
1.63%
Sole
11.91M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares2.34M
TypeSH
Market value$7.08M
1.52%
Sole
2.34M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares84.38K
TypeSH
Market value$6.47M
1.39%
Sole
84.38K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares694.25K
TypeSH
Market value$5.64M
1.21%
Sole
694.25K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares2.27M
TypeSH
Market value$5.62M
1.21%
Sole
2.27M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares153.56K
TypeSH
Market value$5.00M
1.07%
Sole
153.56K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares100K
TypeSH
Market value$4.70M
1.01%
Sole
100K
Shared
0.00
None
0.00
Biontech SE-ADR
SOLEShares40K
TypeSH
Market value$4.56M
0.98%
Sole
40K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$4.24M
0.91%
Sole
515.55K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$3.33M
0.71%
Sole
4.45M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares400K
TypeSH
Market value$2.23M
0.48%
Sole
400K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares49.77K
TypeSH
Market value$2.10M
0.45%
Sole
49.77K
Shared
0.00
None
0.00
AtriCure Inc.
SOLEShares26.80K
TypeSH
Market value$818.9K
0.18%
Sole
26.80K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $182.74M 39.20% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $69.04M 14.81% | 25.95M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 3.29M | SH | $54.01M 11.58% | 3.29M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 770K | SH | $19.79M 4.24% | 770K | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 94.77K | SH | $12.66M 2.72% | 94.77K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 808.79K | SH | $12.04M 2.58% | 808.79K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 76.77K | SH | $12.03M 2.58% | 76.77K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 226K | SH | $9.89M 2.12% | 226K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 171.60K | SH | $9.29M 1.99% | 171.60K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 167.96K | SH | $8.59M 1.84% | 167.96K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.88M | SH | $7.96M 1.71% | 4.88M | 0.00 | 0.00 |
MERUS NVSOLE | COM | 189.10K | SH | $7.95M 1.71% | 189.10K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 11.91M | SH | $7.62M 1.63% | 11.91M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 2.34M | SH | $7.08M 1.52% | 2.34M | 0.00 | 0.00 |
ARCELLX INCSOLE | COM | 84.38K | SH | $6.47M 1.39% | 84.38K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 694.25K | SH | $5.64M 1.21% | 694.25K | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 2.27M | SH | $5.62M 1.21% | 2.27M | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 153.56K | SH | $5.00M 1.07% | 153.56K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 100K | SH | $4.70M 1.01% | 100K | 0.00 | 0.00 |
Biontech SE-ADRSOLE | COM | 40K | SH | $4.56M 0.98% | 40K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $4.24M 0.91% | 515.55K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $3.33M 0.71% | 4.45M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 400K | SH | $2.23M 0.48% | 400K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | COM | 49.77K | SH | $2.10M 0.45% | 49.77K | 0.00 | 0.00 |
AtriCure Inc.SOLE | COM | 26.80K | SH | $818.9K 0.18% | 26.80K | 0.00 | 0.00 |
Page 1 of 2